Legal Opinion
In-Possession, Cantrell Drug Co. v. United States (In re Cantrell Drug Co.)
United States Bankruptcy Court, E.D. Arkansas
Decided April 4, 2018No. Case No. 4:17–bk–16012; AP No. 4:18–ap–1024PublishedCited by 1 opinion
1Opinion of the Court
Phyllis M. Jones, United States Bankruptcy Judge
On March 1, 2018, the Cantrell Drug Company ("Cantrell Drug Company" or the "Debtor") commenced the above-referenced adversary proceeding against the United States of America, the Food and Drug Administration (the "FDA"), Scott Gottlieb, M.D., in his capacity as Commissioner of the FDA, and Thomas E. Price, M.D., Secretary of Health and Human Services (collectively the "Defendants" or "United States"). Also on March 1, 2018, the Debtor filed an Emergency Motion to Extend Automatic Stay and For Preliminary Injunction [Doc. # 4] (the "Emergency…
2Cases cited26 opinions
- Dataphase Systems, Inc. v. C L Systems, Inc.Court of Appeals for the Eighth Circuit · 1981
- Midlantic National Bank v. New Jersey Department of Environmental ProtectionSupreme Court of the United States · 1986
- Board of Governors of the Federal Reserve System v. MCorp Financial, Inc.Supreme Court of the United States · 1991
- United Industries Corp. v. Clorox Co.Court of Appeals for the Eighth Circuit · 1998
- Sandoz Pharmaceuticals Corporation v. Richardson-Vicks, Inc.Court of Appeals for the Third Circuit · 1990
21 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Sis v. Banner Capital BankUnited States Bankruptcy Court, D. Kansas · 2024